Comment on: High tigecycline resistance in multidrug-resistant Acinetobacter baumannii [3]

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 1, 2007, Pages 177-178

  Thamlikitkul, Visanu ^a   Tiengrim, Surapee ^a   Tribuddharat, Chanwit ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

A. baumannii; Glycylcyclines; Susceptibility

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TIGECYCLINE;

ACCURACY; ACINETOBACTER BAUMANNII; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; CONTROLLED STUDY; DILUTION; HUMAN; IN VITRO STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PREDICTION; STATISTICAL SIGNIFICANCE; TEST STRIP; THAILAND;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 34447566042     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm142     Document Type: Letter

References (6)

1. Navon-Venezia S, Leavitt A, Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 2007; 59: 772-4.
2. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement M100-S15. CLSI, Wayne, PA, USA, 2005.
3. Pachon-Ibanez ME, Jimenez-Mejias ME, Pichardo C et al. Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenem. Antimicrob Agents Chemother 2004; 48: 4479-81.
4. Bouchillon SK, Hoban DJ, Johnson BM et al. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004). Diagn Microbiol Infect Dis 2005; 52 173-9.
5. Sader HS, Jones RN, Dowzicky MJ et al. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Diagn Microbiol Infect Dis 2005; 52: 203-8.
6. Jones RN, Ferraro MR, Reller LB et al. Multicenter studies of tige-cycline disk diffusion susceptibility results for Acinetobacter spp. J Clin Microbiol 2007; 35: 227-30.